LifePoint, Inc. (LFPI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2004 | 446.74 Thousand USD | -81.55% |
| 2003 | 2.42 Million USD | 204.39% |
| 2002 | 795.6 Thousand USD | -34.53% |
| 2001 | 1.21 Million USD | 1098.62% |
| 2000 | 101.38 Thousand USD | 0.0% |
| 1999 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2005 Q2 | 199.31 Thousand USD | -34.85% |
| 2005 Q3 | 186.6 Thousand USD | -6.37% |
| 2005 Q1 | 305.94 Thousand USD | -31.52% |
| 2004 FY | 446.74 Thousand USD | -81.55% |
| 2004 Q2 | 589.54 Thousand USD | -83.4% |
| 2004 Q1 | 3.55 Million USD | 46.68% |
| 2004 Q3 | 386.39 Thousand USD | -34.46% |
| 2004 Q4 | 446.74 Thousand USD | 15.62% |
| 2003 Q2 | 535.3 Thousand USD | -19.6% |
| 2003 Q3 | 1.96 Million USD | 266.23% |
| 2003 FY | 2.42 Million USD | 204.39% |
| 2003 Q1 | 665.77 Thousand USD | -16.32% |
| 2003 Q4 | 2.42 Million USD | 23.53% |
| 2002 Q4 | 795.6 Thousand USD | -14.3% |
| 2002 FY | 795.6 Thousand USD | -34.53% |
| 2002 Q3 | 928.36 Thousand USD | -10.7% |
| 2002 Q2 | 1.03 Million USD | -6.24% |
| 2002 Q1 | 1.1 Million USD | -8.75% |
| 2001 Q3 | 1.3 Million USD | 704.29% |
| 2001 Q1 | 184.56 Thousand USD | 82.04% |
| 2001 Q4 | 1.21 Million USD | -7.18% |
| 2001 Q2 | 162.78 Thousand USD | -11.8% |
| 2001 FY | 1.21 Million USD | 1098.62% |
| 2000 Q3 | 225.88 Thousand USD | 200.08% |
| 2000 Q4 | 101.38 Thousand USD | -55.12% |
| 2000 FY | 101.38 Thousand USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q2 | 75.27 Thousand USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | 10.652% |
| Ansell Limited | 855.59 Million USD | 99.948% |
| Ansell Limited | 857.2 Million USD | 99.948% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | 98.007% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -2033.938% |
| Psykey, Inc. | 1.01 Million USD | 55.795% |
| ConvaTec Group Plc | 1.31 Billion USD | 99.966% |
| ConvaTec Group Plc | 1.31 Billion USD | 99.966% |
| Encision Inc. | 1.33 Million USD | 66.491% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 80.65% |
| Innovative MedTech Inc. | 1.87 Million USD | 76.215% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | 91.718% |
| Paradigm Medical Industries, Inc. | 2.18 Million USD | 79.592% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -84.113% |
| SmileDirectClub, Inc. | 871.79 Million USD | 99.949% |
| Sector 10, Inc. | 164 Thousand USD | -172.402% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 99.934% |
| SheerVision, Inc. | 75 Thousand USD | -495.653% |
| United Health Products, Inc. | 755.98 Thousand USD | 40.907% |
| Vasamed, Inc. | 23.45 Thousand USD | -1805.075% |
| Wearable Health Solutions, Inc. | 2.76 Million USD | 83.857% |
| Yubo International Biotech Limited | 790.49 Thousand USD | 43.486% |